Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Milan Luknár"'
Autor:
Laurent Godinas, Keerthana Iyer, Gergely Meszaros, Rozenn Quarck, Pilar Escribano-Subias, Anton Vonk Noordegraaf, Pavel Jansa, Michele D’Alto, Milan Luknar, Senka Milutinov Ilic, Catharina Belge, Olivier Sitbon, Abílio Reis, Stephan Rosenkranz, Joanna Pepke-Zaba, Marc Humbert, Marion Delcroix
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-9 (2021)
Abstract Background During the COVID-19 pandemic, most of the health care systems suspended their non-urgent activities. This included the cancellation of consultations for patients with rare diseases, such as severe pulmonary hypertension (PH), resu
Externí odkaz:
https://doaj.org/article/e7151f016f564639a30ce8eab06920d0
Autor:
Peter Lesny, Milan Luknar, Martin Matejka, Ivan Varga, Peter Solik, Sona Wimmerova, Eva Goncalvesova
Publikováno v:
Biomedical Papers, Vol 160, Iss 2, Pp 257-262 (2016)
Aim: Patients with advanced heart failure (HF) represent a pool of candidates for heart transplantation and long-term mechanical circulatory support devices. The aim of our study was to determine simple and reliable markers of one-year mortality for
Externí odkaz:
https://doaj.org/article/c6a46eff65a943b6b76933f31559253a
Autor:
Xénia Faktorová, Milan Luknár, Zuzana Zelinková, Lucia Horniaková, Eva Mikušková, Michal Šašov, Mária Szántová, Viliam Mojto, Beata Mladosievičová
Publikováno v:
Vnitřní lékařství. 68:E22-E26
Publikováno v:
Journal of Microbiology, Biotechnology and Food Sciences, Vol 2, Iss special issue, Pp 10-11 (2013)
Portopulmonary hypertension (POPH) is associated with a poor prognosis in comparison to some other types of pulmonary arterial hypertension (PAH). Due to various causes of portal hypertension, the subgroup of POPH can be heterogeneous and PAH is cons